What Are Wall Street Analysts' Target Price for Solventum Stock?

Eagan, Minnesota-based Solventum Corporation (SOLV) is a healthcare company with a market cap of $12.9 billion. It develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs.

This healthcare company has considerably underperformed the broader market over the past 52 weeks. Shares of SOLV have gained 2.7% over this time frame, while the broader S&P 500 Index ($SPX) has soared 26.6%. Moreover, on a YTD basis, the stock is down 3.9%, compared to SPX’s 8.1% rise.